Abstract
Various infectious agents affect human health via the oral entrance. The majority of pathogens lack approved vaccines. Oral vaccination is a convenient, safe and cost-effective approach with the potential of provoking mucosal and systemic immunity and maintaining individual satisfaction. However, vaccines should overcome the intricate environment of the gastrointestinal tract (GIT). Oral protein-based antigen vaccines (OPAVs) are easier to administer than injectable vaccines and do not require trained healthcare professionals. Additionally, the risk of needle-related injuries, pain, and discomfort is eliminated. However, OPAVs stability at environmental and GIT conditions should be considered to enhance their stability and facilitate their transport and storage. These vaccines elicit the local immunity, protecting GIT, genital tract and respiratory epithelial surfaces, where numerous pathogens penetrate the body. OPAVs can also be manipulated (such as using specific incorporated ligand and receptors) to elicit targeted immune response. However, low bioavailability of OPAVs necessitates development of proper protein carriers and formulations to enhance their stability and efficacy. There are several strategies to improve their efficacy or protective effects, such as incorporation of adjuvants, enzyme inhibitors, mucoadhesive or penetrating devices and permeation enhancers. Hence, efficient delivery of OPAVs into GIT require proper delivery systems mainly including smart target systems, probiotics, muco-adhesive carriers, lipid- and plant-based delivery systems and nano- and microparticles.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and materials
No underlying data was collected or produced in this study.
References
Aburahma MH (2016) Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Drug Deliv 23:1847–1867. https://doi.org/10.3109/10717544.2014.976892
Amorij J-P et al (2012) Towards tailored vaccine delivery: needs, challenges and perspectives. J Control Release 161:363–376. https://doi.org/10.1016/j.jconrel.2011.12.039
Anam K, Endharti AT, Poeranto S, Sujuti H, Hidayati DYN, Prawiro SR (2022) Shigella flexneri vaccine development: Oral administration of peptides derived from the 49.8 kDa pili protein subunit activates the intestinal immune response in mice. Veterinary World 15:281. https://doi.org/10.14202/vetworld.2022.281-287
Anderluh M et al (2022) Recent advances on smart glycoconjugate vaccines in infections and cancer. Febs j 289:4251–4303. https://doi.org/10.1111/febs.15909
Ashkar A, Sosnik A, Davidovich-Pinhas M (2022) Structured edible lipid-based particle systems for oral drug-delivery. Biotechnol Adv 54:107789. https://doi.org/10.1016/j.biotechadv.2021.107789
Awate S, Babiuk LA, Mutwiri G (2013) Mechanisms of action of adjuvants. Front Immunol 4:114
Baradaran Ghavami S et al (2021) Cross-talk between immune system and microbiota in COVID-19. Exp Rev Gastroenterol Hepatol 15:1281–1294. https://doi.org/10.1080/17474124.2021.1991311
Begines B et al (2020) Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials. https://doi.org/10.3390/nano10071403
Berlin C et al (1993) α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185–195. https://doi.org/10.1016/0092-8674(93)90305-a
Bevins CL, Salzman NH (2011) Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9:356–368. https://doi.org/10.1038/nrmicro2546
Birchenough GM, Johansson ME, Gustafsson JK, Bergström JH, Hansson G (2015) New developments in goblet cell mucus secretion and function. Muc Immunol 8:712–719. https://doi.org/10.1038/mi.2015.32
Bousso P (2008) T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol 8:675–684. https://doi.org/10.1038/nri2379
Brayden DJ, Jepson MA, Baird AW (2005) Keynote review: intestinal Peyer’s patch M cells and oral vaccine targeting. Drug Discov Today 10:1145–1157. https://doi.org/10.1016/s1359-6446(05)03536-1
Brunner R, Jensen-Jarolim E, Pali-Schöll I (2010) The ABC of clinical and experimental adjuvants—a brief overview. Immunol Lett 128:29–35. https://doi.org/10.1016/j.imlet.2009.10.005
Buchy P, Badur S (2020) Who and when to vaccinate against influenza. Int J Infect Dis 93:375–387. https://doi.org/10.1016/j.ijid.2020.02.040
Buettner M, Bode U (2012) Lymph node dissection–understanding the immunological function of lymph nodes. Clin Exp Immunol 169:205–212. https://doi.org/10.1111/j.1365-2249.2012.04602.x
Cai J, Wang H, Wang D, Li Y (2019) Improving cancer vaccine efficiency by nanomedicine. Adv Biosyst 3:1800287. https://doi.org/10.1002/adbi.201800287
Cai F, Li S, Huang H, Iqbal J, Wang C, Jiang X (2022) Green synthesis of gold nanoparticles for immune response regulation: mechanisms, applications, and perspectives. J Biomed Mater Res A 110:424–442. https://doi.org/10.1002/jbm.a.37281
Campbell J, Berry J, Liang Y (2019) Anatomy and physiology of the small intestine. In: Yeo CJ (ed) Shackelford’s surgery of the alimentary tract, 2 volume set. Elsevier, Amsterdam, pp 817–841
Cancro MP, Tomayko MM (2021) Memory B cells and plasma cells: the differentiative continuum of humoral immunity. Immunol Rev 303:72–82. https://doi.org/10.1111/imr.13016
Chakraborty S, Deb B, Nath D, Monoswita D (2022) Identification of promising CD8 and CD4 T cell epitopes for peptide vaccine formulation against SARS-CoV-2. Arch Microbiol 204:242. https://doi.org/10.1007/s00203-022-02845-6
Chelu M et al (2022) Green synthesis of bioinspired chitosan-ZnO-based polysaccharide gums hydrogels with propolis extract as novel functional natural biomaterials. Int J Biol Macromol 211:410–424. https://doi.org/10.1016/j.ijbiomac.2022.05.070
Chen S et al (2016) Inorganic nanomaterials as carriers for drug delivery. J Biomed Nanotechnol 12:1–27. https://doi.org/10.1166/jbn.2016.2122
Chen W et al (2021) CpG-based nanovaccines for cancer immunotherapy. Int J Nanomedicine 16:5281–5299. https://doi.org/10.2147/ijn.s317626
Chen G, Kang W, Li W, Chen S, Gao Y (2022) Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies. Theranostics 12:1419–1439. https://doi.org/10.7150/thno.61747
Chen J et al (2022) Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response. Proc Natl Acad Sci USA 119:e2207841119. https://doi.org/10.1073/pnas.2207841119
Cho C-S et al (2021) Mucosal vaccine delivery using Mucoadhesive polymer particulate systems. Tissue Eng Regen Med 18:693–712. https://doi.org/10.1007/s13770-021-00373-w
Cid R, Bolívar J (2021) Platforms for production of protein-based vaccines: from classical to next-generation strategies. Biomolecules 11:1072. https://doi.org/10.3390/biom11081072
Clark-Wright J, Hudson P, McCloskey C, Carroll S (2020) Burden of selected infectious diseases covered by UK childhood vaccinations: systematic literature review. Future Microbiol 15:1679–1688. https://doi.org/10.2217/fmb-2020-0170
Coombes JL, Powrie F (2008) Dendritic cells in intestinal immune regulation. Nat Rev Immunol 8:435–446. https://doi.org/10.1038/nri2335
Corr SC, Gahan CC, Hill C (2008) M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol 52:2–12. https://doi.org/10.1111/j.1574-695x.2007.00359.x
Corthésy B, Bioley G (2018) Lipid-based particles: versatile delivery systems for mucosal vaccination against infection. Front Immunol 9:431. https://doi.org/10.3389/fimmu.2018.00431
Cui Z, Mumper RJ (2002) Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharm Res 19:947–953. https://doi.org/10.1023/a:1016454003450
Cui R et al (2021) Hydrogel-by-design: smart delivery system for cancer immunotherapy. Front Bioeng Biotechnol 9:723490. https://doi.org/10.3389/fbioe.2021.723490
Darma A, Athiyyah AF, Ranuh RG, Endaryanto A, Budiono B, Sudarmo SM (2020) Effects of probiotics on the enhancement of the innate mucosal immune response against pathogenic bacteria. Iran J Microbiol 12:445. https://doi.org/10.18502/ijm.v12i5.4606
Davitt CJ, Lavelle EC (2015) Delivery strategies to enhance oral vaccination against enteric infections. Adv Drug Deliv Rev 91:52–69. https://doi.org/10.1016/j.addr.2015.03.007
de Araújo DR, Ribeiro LNM, de Paula E (2019) Lipid-based carriers for the delivery of local anesthetics. Expert Opin Drug Deliv 16:701–714. https://doi.org/10.1080/17425247.2019.1629415
DeLano FA, Hoyt DB, Schmid-Schönbein GW (2013) Pancreatic digestive enzyme blockade in the intestine increases survival after experimental shock. Sci Transl Med 5:169ra111. https://doi.org/10.1126/scitranslmed.3005046
Diaz-Dinamarca D et al (2018) Oral vaccine based on a surface immunogenic protein mixed with alum promotes a decrease in Streptococcus agalactiae vaginal colonization in a mouse model. Mol Immunol 103:63–70. https://doi.org/10.1016/j.molimm.2018.08.028
Dillon A, Lo DD (2019) M cells: intelligent engineering of mucosal immune surveillance. Front Immunol 10:1499. https://doi.org/10.3389/fimmu.2019.01499
Elkomy MH, Ali AA, Eid HM (2022) Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review. J Control Release 351:923–940. https://doi.org/10.1016/j.jconrel.2022.10.005
Eloe-Fadrosh EA et al (2013) Impact of oral typhoid vaccination on the human gut microbiota and correlations with S. Typhi-specific immunological responses. PLoS ONE 8:e62026. https://doi.org/10.1371/journal.pone.0062026
Elphick D, Mahida Y (2005) Paneth cells: their role in innate immunity and inflammatory disease. Gut 54:1802–1809. https://doi.org/10.1136/gut.2005.068601
Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 64:557–570. https://doi.org/10.1016/j.addr.2011.12.009
Farhani I, Nezafat N, Mahmoodi S (2019) Designing a novel multi-epitope peptide vaccine against pathogenic Shigella spp. based immunoinformatics approaches. Int J Peptide Res Ther 25:541–553
Faruck MO et al (2020) Polyacrylate–peptide antigen conjugate as a single-dose oral vaccine against Group A Streptococcus. Vaccines 8:23. https://doi.org/10.3390/vaccines8010023
Gaboriau-Routhiau V, Cerf-Bensussan N (2016) Gut microbiota and development of the immune system. Med Sci: M/s 32:961–967. https://doi.org/10.1051/medsci/20163211011
Gala RP et al (2017) Physicochemical and preclinical evaluation of a novel buccal measles vaccine. AAPS PharmSciTech 18:283–292. https://doi.org/10.1208/s12249-016-0566-3
Gao Y et al (2021) Oral administration of Bacillus subtilis subunit vaccine significantly enhances the immune protection of grass carp against GCRV-II infection. Viruses 14:30. https://doi.org/10.3390/v14010030
Garinot M et al (2007) PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 120:195–204. https://doi.org/10.1016/j.jconrel.2007.04.021
Gebre MS, Brito LA, Tostanoski LH, Edwards DK, Carfi A, Barouch DH (2021) Novel approaches for vaccine development. Cell 184:1589–1603. https://doi.org/10.1016/j.cell.2021.02.030
Ghattas M, Dwivedi G, Lavertu M, Alameh M-G (2021) Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities. Vaccines 9:1490. https://doi.org/10.3390/vaccines9121490
Gorantala J et al (2014) Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine. J Biotechnol 176:1–10. https://doi.org/10.1016/j.jbiotec.2014.01.033
Grabovac V, Guggi D, Bernkop-Schnürch A (2005) Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev 57:1713–1723. https://doi.org/10.1016/j.addr.2005.07.006
Gregory AE, Titball R, Williamson D (2013) Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 3:13. https://doi.org/10.3389/fcimb.2013.00013
Gupta PN et al (2012) Development of liposome gel based formulations for intravaginal delivery of the recombinant HIV-1 envelope protein CN54gp140. Eur J Pharm Sci 46:315–322. https://doi.org/10.1016/j.ejps.2012.02.003
Gustafsson JK et al (2021) Intestinal goblet cells sample and deliver lumenal antigens by regulated endocytic uptake and transcytosis. Elife 10:e67292. https://doi.org/10.7554/elife.67292
Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A (2022) Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 182:114097. https://doi.org/10.1016/j.addr.2021.114097
Han HK, Shin HJ, Ha DH (2012) Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur J Pharm Sci 46:500–507. https://doi.org/10.1016/j.ejps.2012.04.002
Hano C, Abbasi BH (2021) Plant-based green synthesis of nanoparticles: production, characterization and applications. Biomolecules. https://doi.org/10.3390/biom12010031
Harris V et al (2016) The infant gut microbiome correlates significantly with rotavirus vaccine response in rural Ghana. J Infect Dis 215:34–41. https://doi.org/10.1093/infdis/jiw518
Hill A, Beitelshees M, Pfeifer BA (2021) Vaccine delivery and immune response basics. Methods Mol Biol 2183:1–8. https://doi.org/10.1007/978-1-0716-0795-4_1
Huang YB, Tsai MJ, Wu PC, Tsai YH, Wu YH, Fang JY (2011) Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J Drug Target 19:709–718. https://doi.org/10.3109/1061186x.2010.551402
Huang X et al (2021) oral probiotic vaccine expressing koi herpesvirus (KHV) ORF81 protein delivered by chitosan-alginate capsules is a promising strategy for mass oral vaccination of carps against KHV infection. J Virol 95:e00415-00421. https://doi.org/10.1128/jvi.00415-21
Huda MN et al (2014) Stool microbiota and vaccine responses of infants. Pediatrics 134:e362–e372. https://doi.org/10.1542/peds.2013-3937
Hume HKC, Lua LH (2017) Platform technologies for modern vaccine manufacturing. Vaccine 35:4480–4485. https://doi.org/10.1016/j.vaccine.2017.02.069
Hunyady B, Mezey E, Palkovits M (2000) Gastrointestinal immunology: cell types in the lamina propria—a morphological review. Acta Physiol Hung 87:305–328
Hutton G, Tediosi F (2006) The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania. Am J Trop Med Hyg 75:119–130. https://doi.org/10.4269/ajtmh.2006.75.119
Iacob AT et al (2021) Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13040587
Jain S, Indulkar A, Harde H, Agrawal AK (2014) Oral mucosal immunization using glucomannosylated bilosomes. J Biomed Nanotechnol 10:932–947. https://doi.org/10.1166/jbn.2014.1800
Jang MH et al (2004) Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci 101:6110–6115. https://doi.org/10.1073/pnas.0400969101
Jazayeri SD, Lim HX, Shameli K, Yeap SK, Poh CL (2021) Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases. Front Pharmacol 12:682286. https://doi.org/10.3389/fphar.2021.682286
Jiang T et al (2014) Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan. Biomaterials 35:2365–2373. https://doi.org/10.1016/j.biomaterials.2013.11.073
Joan SSX et al (2016) Oral vaccine of Lactococcus lactis harbouring pandemic H1N1 2009 haemagglutinin1 and nisP anchor fusion protein elevates anti-HA1 sIgA levels in mice. Biotechnol Lett 38:793–799. https://doi.org/10.1007/s10529-016-2034-2
Kaltsas A, Sepkowitz K (2012) Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host. Curr Opin Infect Dis 25:423–430. https://doi.org/10.1097/qco.0b013e328355660b
Kanaya T, Williams IR, Ohno H (2020) Intestinal M cells: tireless samplers of enteric microbiota. Traffic 21:34–44. https://doi.org/10.1111/tra.12707
Kang SH, Hong SJ, Lee Y-K, Cho S (2018) Oral vaccine delivery for intestinal immunity—biological basis, barriers, delivery system, and m cell targeting. Polymers 10:948. https://doi.org/10.3390/polym10090948
Khan MS et al (2023) Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery. Nanoscale Adv 5:1853–1869. https://doi.org/10.1039/d2na00795a
Kheirollahpour M, Mehrabi M, Dounighi N, Mohammadi M, Masoudi A (2020) Nanoparticles and vaccine development. Pharm Nanotechnol 8(1):6–21. https://doi.org/10.2174/2211738507666191024162042
Kitagawa K et al (2017) Oral combination vaccine, comprising Bifidobacterium displaying hepatitis C virus nonstructural protein 3 and interferon-α, induces strong cellular immunity specific to nonstructural protein 3 in mice. Viral Immunol 30:196–203. https://doi.org/10.1089/vim.2016.0111
Knoop KA, Newberry RD (2018) Goblet cells: multifaceted players in immunity at mucosal surfaces. Mucosal Immunol 11:1551–1557. https://doi.org/10.1038/s41385-018-0039-y
Kujala P et al (2011) Prion uptake in the gut: identification of the first uptake and replication sites. PLoS Pathog 7:e1002449. https://doi.org/10.1371/journal.ppat.1002449
Kunisawa J, Kurashima Y, Kiyono H (2012) Gut-associated lymphoid tissues for the development of oral vaccines. Adv Drug Deliv Rev 64:523–530. https://doi.org/10.1016/j.addr.2011.07.003
Kyzas GZ, Bikiaris DN (2015) Recent modifications of chitosan for adsorption applications: a critical and systematic review. Mar Drugs 13:312–337. https://doi.org/10.3390/md13010312
Lang S, Huang X (2020) Carbohydrate conjugates in vaccine developments. Front Chem 8:284. https://doi.org/10.3389/fchem.2020.00284
Lavelle EC, Ward RW (2022) Mucosal vaccines—fortifying the frontiers. Nat Rev Immunol 22:236–250. https://doi.org/10.1038/s41577-021-00583-2
Lehtoranta L, Latvala S, Lehtinen MJ (2020) Role of probiotics in stimulating the immune system in viral respiratory tract infections: a narrative review. Nutrients 12:3163. https://doi.org/10.3390/nu12103163
Li H-S et al (2016) Nasal immunization with mannan-decorated mucoadhesive HPMCP microspheres containing ApxIIA toxin induces protective immunity against challenge infection with Actinobacillus pleuropneumoiae in mice. J Control Release 233:114–125. https://doi.org/10.1016/j.jconrel.2016.05.032
Li W et al (2019) AuNPs as an important inorganic nanoparticle applied in drug carrier systems. Artif Cells Nanomed Biotechnol 47:4222–4233. https://doi.org/10.1080/21691401.2019.1687501
Li M, Wang Y, Sun Y, Cui H, Zhu SJ, Qiu HJ (2020) Mucosal vaccines: strategies and challenges. Immunol Lett 217:116–125. https://doi.org/10.1016/j.imlet.2019.10.013
Li M, Kaminskas LM, Marasini N (2021) Recent advances in nano/microparticle-based oral vaccines. J Pharmaceut Invest 51:425–438. https://doi.org/10.1007/s40005-021-00537-9
Li S et al (2022) Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges. Drug Deliv 29:1142–1149. https://doi.org/10.1080/10717544.2022.2058646
Liang D et al (2023) Engineering fucoxanthin-loaded probiotics’ membrane vesicles for the dietary intervention of colitis. Biomaterials 297:122107. https://doi.org/10.1016/j.biomaterials.2023.122107
Libanova R, Becker PD, Guzmán CA (2012) Cyclic di-nucleotides: new era for small molecules as adjuvants. Microbial Biotechnol 5:168–176. https://doi.org/10.1111/j.1751-7915.2011.00306.x
Ling SS, Yuen KH, Magosso E, Barker SA (2009) Oral bioavailability enhancement of a hydrophilic drug delivered via folic acid-coupled liposomes in rats. J Pharm Pharmacol 61:445–449. https://doi.org/10.1211/jpp/61.04.0005
Liu T, Guo R (2005) Preparation of a highly stable niosome and its hydrotrope-solubilization action to drugs. Langmuir 21:11034–11039. https://doi.org/10.1021/la051868b
Liu W, Liu J, Triplett L, Leach JE, Wang GL (2014) Novel insights into rice innate immunity against bacterial and fungal pathogens. Annu Rev Phytopathol 52:213–241. https://doi.org/10.1146/annurev-phyto-102313-045926
Liu M et al (2020a) Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection. Vaccine 38:3031–3041. https://doi.org/10.1016/j.vaccine.2020.02.036
Liu Q, Sun Z, Chen L (2020b) Memory T cells: strategies for optimizing tumor immunotherapy. Protein Cell 11:549–564. https://doi.org/10.1007/s13238-020-00707-9
Lu Y et al (2015) Transformable liquid-metal nanomedicine. Nat Commun 6:10066. https://doi.org/10.1038/ncomms10066
Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4+ T cells: differentiation and functions. Clin Dev Immunol. https://doi.org/10.1155/2012/925135
Lv Z et al (2022) Hydrothermal method-assisted synthesis of self-crosslinked all-lignin-based hydrogels. Int J Biol Macromol 216:670–675. https://doi.org/10.1016/j.ijbiomac.2022.07.003
Lycke N (2012) Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 12:592–605. https://doi.org/10.1038/nri3251
Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A (2013) Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol 6:666–677. https://doi.org/10.1038/mi.2013.30
Mahmoodi S, Amirzakaria JZ, Ghasemian A (2023) In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses. PLoS ONE 18:e0285177. https://doi.org/10.1371/journal.pone.0285177
Mali P, Sherje AP (2022) Cellulose nanocrystals: Fundamentals and biomedical applications. Carbohydr Polym 275:118668. https://doi.org/10.1016/j.carbpol.2021.118668
Marwah H, Garg T, Goyal AK, Rath G (2016) Permeation enhancer strategies in transdermal drug delivery. Drug Deliv 23:564–578. https://doi.org/10.3109/10717544.2014.935532
Maurice S, Nussinovitch A, Jaffe N, Shoseyov O, Gertler A (2004) Oral immunization of Carassius auratus with modified recombinant A-layer proteins entrapped in alginate beads. Vaccine 23:450–459. https://doi.org/10.1016/j.vaccine.2004.06.022
McClements DJ (2018) Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: a review. Adv Colloid Interface Sci 253:1–22. https://doi.org/10.1016/j.cis.2018.02.002
McDole JR et al (2012) Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 483:345–349. https://doi.org/10.1038/nature10863
McNeil MM, DeStefano F (2018) Vaccine-associated hypersensitivity. J Allergy Clin Immunol 141:463–472. https://doi.org/10.1016/j.jaci.2017.12.971
Menon I, Bagwe P, Gomes KB, Bajaj L, Gala R, Uddin MN, D’souza MJ, Zughaier SM (2021) Microneedles: a new generation vaccine delivery system. Micromachines 12(4):435
Milcovich G et al (2017) Recent advances in smart biotechnology: hydrogels and nanocarriers for tailored bioactive molecules depot. Adv Colloid Interface Sci 249:163–180. https://doi.org/10.1016/j.cis.2017.05.009
Mitragotri S, Burke PA, Langer R (2014) Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov 13:655–672. https://doi.org/10.1038/nrd4363
Mohammadi E, Golchin M (2020) High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species. Comp Immunol Microbiol Infect Dis 70:101470. https://doi.org/10.1016/j.cimid.2020.101470
Mohsen MO, Zha L, Cabral-Miranda G, Bachmann MF (2017) Major findings and recent advances in virus-like particle (VLP)-based vaccines. Semin Immunol 34:123–132. https://doi.org/10.1016/j.smim.2017.08.014
Mörbe UM et al (2021) Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunol 14:793–802. https://doi.org/10.1038/s41385-021-00389-4
Morin CW, Semenza JC, Trtanj JM, Glass GE, Boyer C, Ebi KL (2018) Unexplored opportunities: use of climate- and weather-driven early warning systems to reduce the burden of infectious diseases. Curr Environ Health Rep 5:430–438. https://doi.org/10.1007/s40572-018-0221-0
Mousavi SM et al (2018) Green synthesis of silver nanoparticles toward bio and medical applications: review study. Artif Cells Nanomed Biotechnol 46:S855-s872. https://doi.org/10.1080/21691401.2018.1517769
Mowat AM, Agace WW (2014) Regional specialization within the intestinal immune system. Nat Rev Immunol 14:667–685. https://doi.org/10.1038/nri3738
Mu H, Holm R (2018) Solid lipid nanocarriers in drug delivery: characterization and design. Expert Opin Drug Deliv 15:771–785. https://doi.org/10.1080/17425247.2018.1504018
Mühlberg E, Burtscher M, Umstätter F, Fricker G, Mier W, Uhl P (2021) Trends in liposomal nanocarrier strategies for the oral delivery of biologics. Nanomedicine 16:1813–1832. https://doi.org/10.2217/nnm-2021-0177
Nakagawa N et al (2022) An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia. Cancer Immunol Immunother. https://doi.org/10.1007/s00262-022-03214-4
Nemati M, Fathi-Azarbayjani A, Al-Salami H, Roshani Asl E, Rasmi Y (2022) Bile acid-based advanced drug delivery systems, bilosomes and micelles as novel carriers for therapeutics. Cell Biochem Funct 40:623–635. https://doi.org/10.1002/cbf.3732
Nezafat N, Eslami M, Negahdaripour M, Rahbar MR, Ghasemi Y (2017) Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches. Mol BioSyst 13:699–713. https://doi.org/10.1039/c6mb00772d
Nguyen TX, Huang L, Gauthier M, Yang G, Wang Q (2016) Recent advances in liposome surface modification for oral drug delivery. Nanomedicine 11:1169–1185. https://doi.org/10.2217/nnm.16.9
Nguyen NTT, Nguyen LM, Nguyen TTT, Nguyen TT, Nguyen DTC, Tran TV (2022a) Formation, antimicrobial activity, and biomedical performance of plant-based nanoparticles: a review. Environ Chem Lett 20:2531–2571. https://doi.org/10.1007/s10311-022-01425-w
Nguyen TT, Nguyen TTD, Tran NM, Van Vo G (2022b) Lipid-based nanocarriers via nose-to-brain pathway for central nervous system disorders. Neurochem Res 47:552–573. https://doi.org/10.1007/s11064-021-03488-7
Ni J, Wu GD, Albenberg L, Tomov VT (2017) Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 14:573–584. https://doi.org/10.1038/nrgastro.2017.88
Nooraei S et al (2021) Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. J Nanobiotechnology 19:59. https://doi.org/10.1186/s12951-021-00806-7
Odeniyi MA, Omoteso OA, Adepoju AO, Jaiyeoba KT (2018) Starch nanoparticles in drug delivery: a review. Polim Med 48:41–45. https://doi.org/10.17219/pim/99993
Oh YJ et al (2021) Ovalbumin and cholera toxin delivery to buccal mucus for immunization using microneedles and comparison of immunological response to transmucosal delivery. Drug Deliv Transl Res 11:1390–1400. https://doi.org/10.1007/s13346-021-00964-z
Oliveira CR, Rezende CM, Silva MR, Pêgo AP, Borges O, Goes AM (2012) A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis. PLoS Negl Trop Dis 6:e1894. https://doi.org/10.1371/journal.pntd.0001894
Ou B, Yang Y, Lv H, Lin X, Zhang M (2023) Current progress and challenges in the study of adjuvants for oral vaccines. BioDrugs. https://doi.org/10.1007/s40259-022-00575-1
Ozbılgın ND, Saka OM, Bozkır A (2014) Preparation and in vitro/in vivo evaluation of mucosal adjuvant in situ forming gels with diphtheria toxoid. Drug Deliv 21:140–147. https://doi.org/10.3109/10717544.2013.834754
Palacio J, Agudelo NA, Lopez BL (2016) PEGylation of PLA nanoparticles to improve mucus-penetration and colloidal stability for oral delivery systems. Curr Opin Chem Eng 11:14–19
Pantazica AM, Cucos LM, Stavaru C, Clarke JL, Branza-Nichita N (2021) Challenges and prospects of plant-derived oral vaccines against hepatitis B and C viruses. Plants. https://doi.org/10.3390/plants10102037
Paris AL, Colomb E, Verrier B, Anjuère F, Monge C (2021) Sublingual vaccination and delivery systems. J Control Release 332:553–562. https://doi.org/10.1016/j.jconrel.2021.03.017
Patel H, Yewale C, Rathi MN, Misra A (2014) Mucosal immunization: a review of strategies and challenges. Crit Rev Ther Drug Carrier Syst 31:273–303. https://doi.org/10.1615/critrevtherdrugcarriersyst.2014010102
Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ (2016) Vaccine hesitancy and healthcare providers. Vaccine 34:6700–6706. https://doi.org/10.1016/j.vaccine.2016.10.042
Patra JK et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 16:1–33. https://doi.org/10.1186/s12951-018-0392-8
Pavot V, Rochereau N, Genin C, Verrier B, Paul S (2012) New insights in mucosal vaccine development. Vaccine 30:142–154. https://doi.org/10.1016/j.vaccine.2011.11.003
Peirotén Á, Landete JM (2020) Natural and engineered promoters for gene expression in Lactobacillus species. Appl Microbiol Biotechnol 104:3797–3805. https://doi.org/10.1007/s00253-020-10426-0
Pelaz B et al (2017) Diverse applications of nanomedicine. ACS Nano 11:2313–2381. https://doi.org/10.1021/acsnano.6b06040
Perera P-Y, Lichy JH, Waldmann TA, Perera LP (2012) The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect 14:247–261. https://doi.org/10.1016/j.micinf.2011.10.006
Perez-Lopez A, Behnsen J, Nuccio SP, Raffatellu M (2016) Mucosal immunity to pathogenic intestinal bacteria. Nat Rev Immunol 16:135–148. https://doi.org/10.1038/nri.2015.17
Peroni DG, Morelli L (2021) Probiotics as adjuvants in vaccine strategy: is there more room for improvement? Vaccines 9:811. https://doi.org/10.3390/vaccines9080811
Perrie Y, Obrenovic M, McCarthy D, Gregoriadis G (2002) Liposome (Lipodine)-mediated DNA vaccination by the oral route. J Liposome Res 12:185–197. https://doi.org/10.1081/lpr-120004792
Perry SL, McClements DJ (2020) Recent advances in encapsulation, protection, and oral delivery of bioactive proteins and peptides using colloidal systems. Molecules 25:1161. https://doi.org/10.3390/molecules25051161
Petkar KC et al (2021) An overview of nanocarrier-based adjuvants for vaccine delivery. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13040455
Pietrzak B, Tomela K, Olejnik-Schmidt A, Mackiewicz A, Schmidt M (2020) Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells. Int J Mol Sci 21:9254. https://doi.org/10.3390/ijms21239254
Pitcovski J et al (2022) Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine. Vaccine 40:1098–1107. https://doi.org/10.1016/j.vaccine.2022.01.025
Poonam P (2007) The biology of oral tolerance and issues related to oral vaccine design. Curr Pharm Des 13:2001–2007. https://doi.org/10.2174/138161207781039814
Premanand B, Prabakaran M, Kiener TK, Kwang J (2013e) Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. PLoS ONE 8:e55536. https://doi.org/10.1371/journal.pone.0055536
Pridgen EM, Alexis F, Farokhzad OC (2014) Polymeric nanoparticle technologies for oral drug delivery. Clin Gastroenterol Hepatol 12:1605–1610. https://doi.org/10.1016/j.cgh.2014.06.018
Pulendran B, Arunachalam PS, O’Hagan DT (2021) Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov 20:454–475. https://doi.org/10.1038/s41573-021-00163-y
Qiu M, Jiang H, Ren G, Huang J, Wang X (2013) Effect of chitosan coatings on postharvest green asparagus quality. Carbohydr Polym 92:2027–2032. https://doi.org/10.1016/j.carbpol.2012.11.070
Ramirez JEV, Sharpe LA, Peppas NA (2017) Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev 114:116–131. https://doi.org/10.1016/j.addr.2017.04.008
Ramon G (1924) Sur la toxine et sur l’anatoxine diphtheriques. Ann Inst Pasteur 38:13
Rao C et al (2022) Novel formulations of metal-organic frameworks for controlled drug delivery. Expert Opin Drug Deliv 19:1183–1202. https://doi.org/10.1080/17425247.2022.2064450
Renukuntla J, Vadlapudi AD, Patel A, Boddu SH, Mitra AK (2013) Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 447:75–93. https://doi.org/10.1016/j.ijpharm.2013.02.030
Richard J (2017) Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects. Ther Deliv 8:663–684. https://doi.org/10.4155/tde-2017-0024
Roldão A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9:1149–1176. https://doi.org/10.1586/erv.10.115
Romero EL, Morilla MJ (2011) Topical and mucosal liposomes for vaccine delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3:356–375. https://doi.org/10.1002/wnan.131
Ruth MR, Field CJ (2013) The immune modifying effects of amino acids on gut-associated lymphoid tissue. J Anim Sci Biotechnol 4:1–10. https://doi.org/10.1186/2049-1891-4-27
Salem MF, Abd-Elraoof WA, Tayel AA, Alzuaibr FM, Abonama OM (2022) Antifungal application of biosynthesized selenium nanoparticles with pomegranate peels and nanochitosan as edible coatings for citrus green mold protection. J Nanobiotechnology 20:182. https://doi.org/10.1186/s12951-022-01393-x
Schneider WDH, Dillon AJP, Camassola M (2021) Lignin nanoparticles enter the scene: A promising versatile green tool for multiple applications. Biotechnol Adv 47:107685. https://doi.org/10.1016/j.biotechadv.2020.107685
Shahid N, Daniell H (2016) Plant-based oral vaccines against zoonotic and non-zoonotic diseases. Plant Biotechnol J 14:2079–2099. https://doi.org/10.1111/pbi.12604
Shen H, Aggarwal N, Wun KS, Lee YS, Hwang IY, Chang MW (2022) Engineered microbial systems for advanced drug delivery. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2022.114364
Shimizu T, Kawaguchi Y, Ando H, Ishima Y, Ishida T (2022) Development of an antigen delivery system for a B cell-targeted vaccine as an alternative to dendritic cell-targeted vaccines. Chem Pharm Bull 70:341–350. https://doi.org/10.1248/cpb.c22-00047
Silveira MM, Moreira GMSG, Mendonça M (2021) DNA vaccines against COVID-19: Perspectives and challenges. Life Sci 267:118919. https://doi.org/10.1016/j.lfs.2020.118919
Singh B, Maharjan S, Jiang T, Kang S-K, Choi Y-J, Cho C-S (2015a) Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum. Biomaterials 59:144–159. https://doi.org/10.1016/j.biomaterials.2015.04.017
Singh B, Maharjan S, Jiang T, Kang S-K, Choi Y-J, Cho C-S (2015b) Combinatorial approach of antigen delivery using M cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccine. Mol Pharmaceut 12:3816–3828. https://doi.org/10.1021/acs.molpharmaceut.5b00265
Skwarczynski M, Toth I (2016) Peptide-based synthetic vaccines. Chem Sci 7:842–854. https://doi.org/10.1039/c5sc03892h
Skwarczynski M, Toth I (2020) Non-invasive mucosal vaccine delivery: advantages, challenges and the future. Expert Opin Drug Deliv 17:435–437. https://doi.org/10.1080/17425247.2020.1731468
Smith KA (2011) Edward Jenner and the small pox vaccine. Front Immunol 2:21. https://doi.org/10.3389/fimmu.2011.00021
Song S et al (2019) Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses. Vaccine 37:4364–4369. https://doi.org/10.1016/j.vaccine.2019.06.026
Song SJ et al (2021) Plant-based, adjuvant-free, potent multivalent vaccines for avian influenza virus via Lactococcus surface display. J Integr Plant Biol 63:1505–1520. https://doi.org/10.1111/jipb.13141
Sriwidodo, Umar AK, Wathoni N, Zothantluanga JH, Das S, Luckanagul JA (2022) Liposome-polymer complex for drug delivery system and vaccine stabilization. Heliyon 8:e08934. https://doi.org/10.1016/j.heliyon.2022.e0893
St Paul M, Ohashi PS (2020) The roles of CD8(+) T cell subsets in antitumor immunity. Trends Cell Biol 30:695–704. https://doi.org/10.1016/j.tcb.2020.06.003
Sun J et al (2022) Immunological effects of recombinant lactobacillus casei expressing IHNV G protein and rainbow trout (Oncorhynchus mykiss) chemokine CK6 as an oral vaccine. Front Immunol. https://doi.org/10.3389/fimmu.2022.927443
Sung JC-C et al (2022) Expression of SARS-CoV-2 spike protein receptor binding domain on recombinant B. subtilis on spore surface: a potential COVID-19 oral vaccine candidate. Vaccines. https://doi.org/10.3390/vaccines10111852
Taddio A et al (2012) Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine 30:4807–4812. https://doi.org/10.1016/j.vaccine.2012.05.011
Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y (2003) Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 86:235–242. https://doi.org/10.1016/s0168-3659(02)00411-x
Tan M, Jiang X (2017) Recent advancements in combination subunit vaccine development. Hum Vaccin Immunother 13:180–185. https://doi.org/10.1080/21645515.2016.1229719
Taniuchi I (2018) CD4 helper and CD8 cytotoxic T cell differentiation. Annu Rev Immunol 36:579–601. https://doi.org/10.1146/annurev-immunol-042617-053411
Tseng Y-H, Hsieh C-C, Kuo T-Y, Liu J-R, Hsu T-Y, Hsieh S-C (2019) Construction of a Lactobacillus plantarum Strain expressing the capsid protein of porcine circovirus type 2d (PCV2d) as an oral vaccine. Indian J Microbiol 59:490–499. https://doi.org/10.1007/s12088-019-00827-9
Uddin MN, Allon A, Roni MA, Kouzi S (2019) Overview and future potential of fast dissolving buccal films as drug delivery system for vaccines. J Pharm Pharm Sci 22:388–406. https://doi.org/10.18433/jpps30528
Vajdy M, Srivastava I, Polo J, Donnelly J, O’hagan D, Singh M (2004) Mucosal adjuvants and delivery systems for protein, DNA and RNA-based vaccines. Immunol Cell Biol 82:617–627. https://doi.org/10.1111/j.1440-1711.2004.01288.x
Varanko A, Saha S, Chilkoti A (2020) Recent trends in protein and peptide-based biomaterials for advanced drug delivery. Adv Drug Deliv Rev 156:133–187. https://doi.org/10.1016/j.addr.2020.08.008
Verbist KC, Klonowski KD (2012) Functions of IL-15 in anti-viral immunity: multiplicity and variety. Cytokine 59:467–478. https://doi.org/10.1016/j.cyto.2012.05.020
Verma S, Goand UK, Husain A, Katekar RA, Garg R, Gayen JR (2021) Challenges of peptide and protein drug delivery by oral route: current strategies to improve the bioavailability. Drug Dev Res 82:927–944. https://doi.org/10.1002/ddr.21832
Villablanca EJ, Russo V, Rodrigo Mora J (2008) Dendritic cell migration and lymphocyte homing imprinting. Histol Histopathol 7:897–910. https://doi.org/10.14670/hh-23.897
Vyas K, Rathod M, Patel MM (2023) Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer. Nanomedicine 49:102662. https://doi.org/10.1016/j.nano.2023.102662
Walvekar P, Kumar P, Choonara YE (2023) Long-acting vaccine delivery systems. Adv Drug Deliv Rev 198:114897. https://doi.org/10.1016/j.addr.2023.114897
Wang M, Johnson S (2014) Enteric infections. Cancer Treat Res 161:237–251. https://doi.org/10.1007/978-3-319-04220-6_8
Wang Z, Yu Q, Gao J, Yang Q (2012) Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1. Clin Vaccine Immunol 19:174–179. https://doi.org/10.1128/cvi.05618-11
Wang S, Liu H, Zhang X, Qian F (2015) Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies. Protein Cell 6:480–503. https://doi.org/10.1007/s13238-015-0164-2
Wang J et al (2020) Construction and evaluation of recombinant Lactobacillus plantarum NC8 delivering one single or two copies of G protein fused with a DC-targeting peptide (DCpep) as novel oral rabies vaccine. Vet Microbiol 251:108906. https://doi.org/10.1016/j.vetmic.2020.108906
Ways TMM, Lau WM, Khutoryanskiy VV (2018) Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polymers. https://doi.org/10.3390/polym10030267
Wei W et al (2021) Chitosan nanoparticles loaded with truncated ORF2 protein as an oral vaccine candidate against hepatitis E. Macromol Biosci 21:2000375. https://doi.org/10.1002/mabi.202000375
Werle M, Takeuchi H (2009) Chitosan-aprotinin coated liposomes for oral peptide delivery: development, characterisation and in vivo evaluation. Int J Pharm 370:26–32. https://doi.org/10.1016/j.ijpharm.2008.11.013
Wilkhu JS, McNeil SE, Anderson DE, Perrie Y (2013) Characterization and optimization of bilosomes for oral vaccine delivery. J Drug Target 21:291–299. https://doi.org/10.3109/1061186x.2012.747528
Willard-Mack CL (2006) Normal structure, function, and histology of lymph nodes. Toxicol Pathol 34:409–424. https://doi.org/10.1080/01926230600867727
Wu X, Farooq MA, Li T, Geng T, Kutoka PT, Wang B (2021) Cationic chitosan-modified silica nanoparticles for oral delivery of protein vaccine. J Biomed Mater Res Part A 109:2111–2119. https://doi.org/10.1002/jbm.a.37198
Xu B, Zhang W, Chen Y, Xu Y, Wang B, Zong L (2018) Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery. Int J Biol Macromol 113:534–542. https://doi.org/10.1016/j.ijbiomac.2018.02.016
Xu Y, Shrestha N, Préat V, Beloqui A (2020) Overcoming the intestinal barrier: a look into targeting approaches for improved oral drug delivery systems. J Control Release 322:486–508. https://doi.org/10.1016/j.jconrel.2020.04.006
Xu Y, Fourniols T, Labrak Y, Préat V, Beloqui A, des Rieux A (2022) Surface Modification of Lipid-Based Nanoparticles. ACS Nano 16:7168–7196. https://doi.org/10.1021/acsnano.2c02347
Yan F, Polk D (2011) Probiotics and immune health. Curr Opin Gastroenterol 27:496. https://doi.org/10.1097/mog.0b013e32834baa4d
Yasmin F et al (2022) Novel drug delivery systems for inflammatory bowel disease. World J Gastroenterol 28:1922–1933. https://doi.org/10.3748/wjg.v28.i18.1922
Yu Y, Ma X, Gong R, Zhu J, Wei L, Yao J (2018) Recent advances in CD8(+) regulatory T cell research. Oncol Lett 15:8187–8194. https://doi.org/10.3892/ol.2018.8378
Zeng L (2016) Mucosal adjuvants: opportunities and challenges. Hum Vaccin Immunother 12:2456–2458. https://doi.org/10.1080/21645515.2016.1181236
Zhang X, Qi J, Lu Y, He W, Li X, Wu W (2014) Biotinylated liposomes as potential carriers for the oral delivery of insulin. Nanomedicine 10:167–176. https://doi.org/10.1016/j.nano.2013.07.011
Zhang Y, Li M, Du G, Chen X, Sun X (2021a) Advanced oral vaccine delivery strategies for improving the immunity. Adv Drug Deliv Rev 177:113928. https://doi.org/10.1016/j.addr.2021.113928
Zhang Y, Sun C, Wang C, Jankovic KE, Dong Y (2021b) Lipids and lipid derivatives for RNA delivery. Chem Rev 121:12181–12277. https://doi.org/10.1021/acs.chemrev.1c00244
Zhang Q et al (2023) Intraduodenal delivery of exosome-loaded SARS-CoV-2 RBD mRNA induces a neutralizing antibody response in mice. Vaccines. https://doi.org/10.3390/vaccines11030673
Zhu J (2015) T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine 75:14–24. https://doi.org/10.1016/j.cyto.2015.05.010
Zhu X, Zhu J (2020) CD4 T helper cell subsets and related human immunological disorders. Int J Mol Sci 21:8011. https://doi.org/10.3390/ijms21218011
Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28:445–489. https://doi.org/10.1146/annurev-immunol-030409-101212
Zielińska A et al (2020) Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules. https://doi.org/10.3390/molecules25163731
Zong Z, Tian G, Wang J, Fan C, Yang F, Guo F (2022) Recent advances in metal-organic-framework-based nanocarriers for controllable drug delivery and release. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14122790
Zwirner NW, Ziblat A (2017) Regulation of NK cell activation and effector functions by the IL-12 family of cytokines: the case of IL-27. Front Immunol 8:25. https://doi.org/10.3389/fimmu.2017.00025
Acknowledgements
This study has been written by the authors.
Funding
No funding was received by this study.
Author information
Authors and Affiliations
Contributions
PH and SM conceptualized the study and wrote the draft. AG wrote the draft and edited the manuscript. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Communicated by Yusuf Akhter.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hashemi, P., Mahmoodi, S. & Ghasemian, A. An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases. Arch Microbiol 205, 289 (2023). https://doi.org/10.1007/s00203-023-03629-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00203-023-03629-2